May 4, 2020 / 5:07 AM / a month ago

BRIEF-Targovax Releases Update For Mesothelioma Trial Combining ONCOS-102 And Chemotherapy

May 4 (Reuters) - Targovax ASA:

* TARGOVAX RELEASES UPDATE FOR MESOTHELIOMA TRIAL COMBINING ONCOS-102 AND CHEMOTHERAPY

* IMMUNE ACTIVATION IS FURTHER VALIDATED IN ONCOS-102 TREATED GROUP

* FIRST LINE MESOTHELIOMA REMAINS FOCUS FOR NEXT PHASE OF DEVELOPMENT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below